trial
as of 2026-07-01Valproate in Dementia (VALID)
NCTId NCT00071721
at a glance
Phase 3 · Completed
Enrollment 313 (actual)
Sponsored by Alzheimer's Disease Cooperative Study (ADCS)
Primary completion 2009-02
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 3
Status
Completed
Enrollment
313 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2003-10
Primary completion
2009-02
Eligibility
ALL · 55 Years · 90 Years
Interventions & indications
Sponsors
Alzheimer's Disease Cooperative Study (ADCS)Lead Sponsor
National Institute on Aging (NIA)Collaborator
Investigators
1
Pierre Tariot, MDStudy Director
Sites
46 total
Sun City, United StatesTucson, United StatesIrvine, United StatesLa Jolla, United StatesLong Beach, United StatesLos Angeles, United StatesLos Angeles, United StatesLos Angeles, United StatesSan Diego, United StatesStanford, United StatesNew Haven, United StatesWashington D.C., United States
Linked catalysts
1
Facts & assertions
4 sourced
Enrollment
313
Phase
PHASE3
Primary Completion Date
2009-02
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
collaborator
indication
investigator
person